Axsome Therapeutics Inc. (AXSM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Axsome Therapeutics Inc.

    NASDAQ: AXSM · Real-Time Price · USD
    120.30
    0.36 (0.30%)
    At close: Oct 03, 2025, 3:59 PM
    121.89
    1.32%
    Pre-market: Oct 06, 2025, 07:58 AM EDT

    Axsome Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -14.11 -15.11 -15.86 -10.53
    PEG Ratio
    		 -1.03 -1.79 -0.45 -0.39
    PS Ratio
    		 10.51 13.36 62.67 n/a
    PB Ratio
    		 71.10 18.93 28.62 -3.47
    P/FCF Ratio
    		 -31.5 -24.82 -26.75 -13.09
    P/OCF Ratio
    		 -31.57 -24.92 -26.91 -13.13
    OCF/S Ratio
    		 -0.33 -0.54 -2.33 n/a
    Debt / Equity Ratio
    		 3.38 0.98 0.86 -0.12
    Quick Ratio
    		 2.04 3.52 2.50 3.75
    Current Ratio
    		 2.11 3.63 2.54 3.75
    Asset Turnover
    		 0.68 0.46 0.15 n/a
    Interest Coverage
    		 -42.71 -35.93 -24.06 -21.89
    Return on Equity
    		 -5.04 -1.25 -1.81 0.33
    Return on Assets
    		 -0.51 -0.41 -0.6 0.40
    Return on Invested Capital
    		 -0.82 -0.52 -0.79 -1.91
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.91 0.90 0.90 n/a
    Net Profit Margin
    		 -0.74 -0.88 -3.95 n/a
    Pretax Profit Margin
    		 -0.74 -0.88 -3.74 n/a
    Operating Profit Margin
    		 -0.73 -0.86 -3.53 n/a
    FCF Margin
    		 -0.33 -0.54 -2.34 n/a
    EBITDA Margin
    		 -0.71 -0.83 -3.48 n/a

    Add to Watchlist